fig1

Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins

Figure 1. Main types and composition of nanocarriers used for cancer treatment and/or imaging (A); how can the nanocarrier be modified to target cancer cells (B)

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/